CCG-203971
CAS: 1443437-74-8
Ref. TM-T4306
5mg | 36.00 € | ||
10mg | 56.00 € | ||
25mg | 94.00 € | ||
50mg | 164.00 € | ||
100mg | 245.00 € | ||
500mg | 597.00 € | ||
1ml*10 (DMSO) | 40.00 € |
Product Information
- CCG203971
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
Chemical properties
Technical inquiry about: TM-T4306 CCG-203971
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.